This inventor holds 1 USPTO granted patent. Top assignees: Victoria Link Limited, Other. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 53 
1 out of 834,601 Years Active: 2021
Title: Andrew Munkacsi: Innovator in Glycomimetic Compounds
Introduction
Andrew Munkacsi is a notable inventor based in Wellington, New Zealand. He has made significant contributions to the field of pharmaceuticals and cosmeceuticals through his innovative research and development.
Latest Patents
Munkacsi holds a patent for "Heparan sulfate glycomimetic compounds and their pharmaceutical and cosmeceutical uses." This invention relates to dendritic compounds and their applications in treating various medical conditions, including cancer, inflammation, diabetic nephropathy, neurodegenerative disorders, Niemann-Pick Type C disease, and dermatological conditions. His work in this area has the potential to impact numerous therapeutic approaches.
Career Highlights
Throughout his career, Munkacsi has worked with Victoria Link Limited, where he has furthered his research and development efforts. His dedication to innovation in the pharmaceutical field has established him as a key figure in his area of expertise.
Collaborations
Munkacsi has collaborated with notable individuals such as Jeremy E Turnbull and Peter Charles Tyler. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Andrew Munkacsi's work in glycomimetic compounds showcases his commitment to advancing pharmaceutical and cosmeceutical applications. His innovative contributions are paving the way for new treatments and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile